Corcept Therapeutics Incorporated (CORT)
Who owns Corcept Therapeutics Incorporated (CORT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 83.8% of the shares are freely tradable; institutional investors hold 75.7%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 11.32 | 12,151,276 | +0.7 | 03/31/2026 |
| Vanguard Group Inc | 8.84 | 9,494,822 | -0.4 | 12/31/2025 |
| Ingalls & Snyder LLC | 7.09 | 7,608,716 | +5.7 | 03/31/2026 |
| Renaissance Technologies Corp | 5.29 | 5,682,783 | -1.3 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 4.49 | 4,820,568 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.80 | 4,077,196 | +0.0 | 03/31/2026 |
| Parallel Advisors, LLC | 3.71 | 3,977,404 | +2.5 | 03/31/2026 |
| State Street Corp | 2.98 | 3,200,946 | +7.2 | 03/31/2026 |
| FMR Inc | 2.97 | 3,190,192 | +32.1 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 5.29 | 5,679,723 | +0.0 | 05/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 15. Jul 2026 | Wilson James N | Director | Sell | 1,978 | 89.49 | 177,007 |
| 15. Jul 2026 | Wilson James N | Director | Sell | 2,974 | 88.81 | 264,122 |
| 15. Jul 2026 | Wilson James N | Director | Sell | 3,969 | 87.74 | 348,223 |
| 15. Jul 2026 | Wilson James N | Director | Sell | 1,079 | 86.78 | 93,633 |
| 15. Jul 2026 | Mokari Atabak | Chief Financial Officer | Sell | 101 | 89.43 | 9,032 |
| 15. Jul 2026 | Mokari Atabak | Chief Financial Officer | Sell | 3,520 | 88.30 | 310,822 |
| 15. Jul 2026 | Mokari Atabak | Chief Financial Officer | Sell | 28,460 | 87.89 | 2,501,244 |
| 15. Jul 2026 | Mokari Atabak | Chief Financial Officer | Sell | 7,919 | 86.78 | 687,179 |
| 15. Jul 2026 | Mokari Atabak | Chief Financial Officer | Other | 24,167 | 23.06 | 557,291 |
| 15. Jul 2026 | Mokari Atabak | Chief Financial Officer | Other | 15,833 | 19.26 | 304,944 |
| 7. Jul 2026 | Guyer William | Chief Development Officer | Sell | 952 | 93.54 | 89,048 |
| 7. Jul 2026 | Guyer William | Chief Development Officer | Sell | 19,048 | 93.11 | 1,773,481 |
| 7. Jul 2026 | Guyer William | Chief Development Officer | Other | 20,000 | 21.65 | 433,000 |
| 27. May 2026 | Robb Gary Charles | Chief Business Officer | Other | 600 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.